Literature DB >> 11529230

Treatment of brain metastases of malignant melanoma with temozolomide.

G Biasco, M A Pantaleo, S Casadei.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11529230     DOI： 10.1056/NEJM200108233450817

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  10 in total

Review 1.  Radiotherapy and chemotherapy of brain metastases.

Authors:  R Soffietti; A Costanza; E Laguzzi; M Nobile; R Rudà
Journal:  J Neurooncol       Date:  2005-10       Impact factor: 4.130

2.  Potentiation of temozolomide cytotoxicity by inhibition of DNA polymerase beta is accentuated by BRCA2 mutation.

Authors:  Gregory C Stachelek; Shibani Dalal; Katherine A Donigan; Denise Campisi Hegan; Joann B Sweasy; Peter M Glazer
Journal:  Cancer Res       Date:  2009-12-22       Impact factor: 12.701

3.  Downregulation of hPMC2 imparts chemotherapeutic sensitivity to alkylating agents in breast cancer cells.

Authors:  Nirmala Krishnamurthy; Lili Liu; Xiahui Xiong; Junran Zhang; Monica M Montano
Journal:  Cancer Biol Ther       Date:  2015-04-07       Impact factor: 4.742

4.  Whole brain irradiation and temozolomide based chemotherapy in melanoma brain metastases.

Authors:  Carlos Conill; Sandra Jorcano; Josep Domingo-Doménech; Rosa Gallego; Josep Malvehy; Susana Puig; Marcelo Sánchez; Ramón Vilella; Teresa Castel
Journal:  Clin Transl Oncol       Date:  2006-04       Impact factor: 3.405

5.  Temozolomide with or without radiotherapy in melanoma with unresectable brain metastases.

Authors:  Maja Hofmann; Felix Kiecker; Reinhard Wurm; Lorenz Schlenger; Volker Budach; Wolfram Sterry; Uwe Trefzer
Journal:  J Neurooncol       Date:  2006-01       Impact factor: 4.130

6.  Myeloablative temozolomide enhances CD8⁺ T-cell responses to vaccine and is required for efficacy against brain tumors in mice.

Authors:  Luis A Sanchez-Perez; Bryan D Choi; Gary E Archer; Xiuyu Cui; Catherine Flores; Laura A Johnson; Robert J Schmittling; David Snyder; James E Herndon; Darell D Bigner; Duane A Mitchell; John H Sampson
Journal:  PLoS One       Date:  2013-03-18       Impact factor: 3.240

7.  Temozolomide in malignant glioma.

Authors:  Gregor Dresemann
Journal:  Onco Targets Ther       Date:  2010-09-07       Impact factor: 4.147

8.  Incidence of radiation-induced leukoencephalopathy after whole brain radiotherapy in patients with brain metastases.

Authors:  C Conill; J Berenguer; M Vargas; A López-Soriano; I Valduvieco; J Marruecos; R Vilella
Journal:  Clin Transl Oncol       Date:  2007-09       Impact factor: 3.405

Review 9.  Therapeutic implications of cellular and molecular biology of cancer stem cells in melanoma.

Authors:  Dhiraj Kumar; Mahadeo Gorain; Gautam Kundu; Gopal C Kundu
Journal:  Mol Cancer       Date:  2017-01-30       Impact factor: 27.401

10.  Neuraxis Metastases Of Primary Central Nervous System Tumors: A Review Of Clinicopathological And Radiographic Characters Of 198 Cases In A Single Center.

Authors:  Hailong Liu; Junping Zhang; Yongqiang Liu; Youliang Sun; Cheng Li; Chunyu Gu; Haoran Wang; Hongwei Zhang; Chunjiang Yu; Mingshan Zhang
Journal:  Cancer Manag Res       Date:  2019-11-20       Impact factor: 3.989
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.